VWR Corp (NASDAQ:VWR) has received an average rating of “Hold” from the six ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $34.50.
A number of analysts recently commented on the company. ValuEngine downgraded VWR from a “buy” rating to a “hold” rating in a research report on Wednesday, October 11th. BidaskClub downgraded VWR from a “sell” rating to a “strong sell” rating in a research report on Friday, October 13th. Finally, Zacks Investment Research raised VWR from a “hold” rating to a “buy” rating and set a $37.00 target price for the company in a research report on Thursday, November 9th.
A number of large investors have recently added to or reduced their stakes in the business. Aperio Group LLC increased its position in VWR by 7.5% in the third quarter. Aperio Group LLC now owns 53,329 shares of the medical research company’s stock worth $1,766,000 after buying an additional 3,721 shares during the last quarter. Amalgamated Bank boosted its holdings in shares of VWR by 37.9% in the second quarter. Amalgamated Bank now owns 15,445 shares of the medical research company’s stock worth $510,000 after acquiring an additional 4,243 shares during the period. Colony Group LLC boosted its holdings in shares of VWR by 6.5% in the second quarter. Colony Group LLC now owns 144,191 shares of the medical research company’s stock worth $4,760,000 after acquiring an additional 8,835 shares during the period. Crossmark Global Holdings Inc. bought a new position in shares of VWR in the third quarter worth $318,000. Finally, Schroder Investment Management Group boosted its holdings in shares of VWR by 0.6% in the third quarter. Schroder Investment Management Group now owns 2,987,927 shares of the medical research company’s stock worth $98,871,000 after acquiring an additional 18,316 shares during the period. 96.66% of the stock is owned by institutional investors and hedge funds.
Shares of VWR (NASDAQ VWR) remained flat at $$33.25 on Friday. 2,797,942 shares of the company traded hands, compared to its average volume of 983,321. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.09. The company has a market capitalization of $4,380.00 and a PE ratio of 29.17. VWR has a fifty-two week low of $24.42 and a fifty-two week high of $37.25.
VWR (NASDAQ:VWR) last issued its quarterly earnings results on Tuesday, November 7th. The medical research company reported $0.54 EPS for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.08. The company had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.16 billion. VWR had a return on equity of 11.79% and a net margin of 4.11%. VWR’s revenue was up 5.2% on a year-over-year basis. During the same period last year, the business posted $0.44 earnings per share. equities analysts forecast that VWR will post 1.85 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “VWR Corp (VWR) Receives $34.50 Consensus Price Target from Brokerages” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/02/04/vwr-corp-vwr-receives-34-50-consensus-price-target-from-brokerages.html.
VWR Company Profile
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR and related companies with MarketBeat.com's FREE daily email newsletter.